Institute of Human Genetics, Polish Academy of Sciences, Strzeszyńska 32, 60-479 Poznań, Poland.
Cancer Genetics Unit, Cancer Prevention Department, The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, 02-781 Warsaw, Poland.
Int J Mol Sci. 2023 Sep 26;24(19):14548. doi: 10.3390/ijms241914548.
Multiple polyposes are heterogeneous diseases with different underlying molecular backgrounds, sharing a common symptom: the presence of transforming into cancerous intestinal polyps. Recent reports have indicated biallelic mutations in the gene, which is involved in base excision repair (BER), as predisposing to an elevated risk of colorectal cancer (CRC). We aimed to evaluate the significance of the p.Q82* truncating variant in predisposition to intestinal polyposis by assessing its frequency in polyposis patients. We genotyped 644 Polish patients and 634 control DNA samples using high-resolution melting analysis (HRM) and Sanger sequencing. We found the p.Q82* variant in four polyposis patients; in three, it was homozygous (OR = 6.90, value = 0.202). Moreover, the p.R92C mutation was detected in one patient. We also looked more closely at the disease course in patients carrying mutations. Two homozygous patients also presented other neoplasia. In the family case, we noticed the earlier presence of polyps in the proband and early hepatoblastoma in his brother. We cannot univocally confirm the relationship of p.Q82* with an increased risk of CRC. However, homozygous p.Q82* was more frequent by 10-fold in patients without other mutations identified, which makes gene screening in this group reasonable.
多发性息肉是具有不同潜在分子背景的异质性疾病,具有共同的症状:存在转化为癌性肠息肉的风险。最近的报告表明,参与碱基切除修复 (BER) 的 基因的双等位基因突变与结直肠癌 (CRC) 的风险升高有关。我们旨在通过评估其在肠息肉形成倾向中的频率来评估 p.Q82截断变异体在易感性中的意义。我们使用高分辨率熔解分析 (HRM) 和 Sanger 测序对 644 名波兰患者和 634 名对照 DNA 样本进行了基因分型。我们在四名息肉病患者中发现了 p.Q82 变体;其中三人是纯合子(OR = 6.90, 值= 0.202)。此外,还在一名患者中检测到 p.R92C 突变。我们还更仔细地研究了携带 突变的患者的疾病过程。两名纯合子患者还存在其他肿瘤。在家族病例中,我们注意到先证者的息肉更早出现,并且他的兄弟患有早期肝母细胞瘤。我们不能明确证实 p.Q82与 CRC 风险增加之间的关系。然而,在未发现其他突变的患者中,p.Q82的纯合子频率增加了 10 倍,这使得对该组进行 基因筛查是合理的。